Figures
Fig 10 is incorrect. Please see the correct Fig 10 here.
(A)diS-C3(3) fluorescence of wild type AH109 yeast cells suspensions at different concentrations of amiodarone. (B)diS-C3(3) fluorescence of wild type AH109 yeast cells suspensions at different concentrations of auroramycin. (C)diS-C3(3) fluorescence of wild type AH109 yeast cells suspensions at different concentrations of auroramycin-aglycon. (D)Ratio of fluorescence at 585 nm to 575 nm is plotted for various cultures treated in A-C. Error bars (n = 3 Mean ± S.D) are indicated in the plot. Asterisks indicate statistical significance of fluorescence ratios for amiodarone/auroramycin-treated cells versus DMSO-treated cells, as determined by the Student’s t test (**, 2-sided P < 0.01 and *, 2-sided P< 0.05). This experiment was performed twice and data from one experiment are shown here.
Reference
- 1. Wong JH, Alfatah M, Kong KW, Hoon S, Yeo WL, Ching KC, et al. (2019) Chemogenomic profiling in yeast reveals antifungal mode-of-action of polyene macrolactam auroramycin. PLoS ONE 14(6): e0218189. https://doi.org/10.1371/journal.pone.0218189 pmid:31181115
Citation: Wong JH, Alfatah M, Kong KW, Hoon S, Yeo WL, Ching KC, et al. (2019) Correction: Chemogenomic profiling in yeast reveals antifungal mode-of-action of polyene macrolactam auroramycin. PLoS ONE 14(8): e0221074. https://doi.org/10.1371/journal.pone.0221074
Published: August 8, 2019
Copyright: © 2019 Wong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.